# Chapter ingest — Simon & Aliferis (2024) · Selective Ch.11 (Book Ch.17: Reporting Standards)

| Field | Value |
|-------|-------|
| slug | simon_aliferis_healthcare_2024 |
| source_type | textbook |
| text_path | /Users/dubs/Projects/scholia.skill/literature/cs-ai-textbook-canon/text/simon_aliferis_healthcare_2024.txt |
| ingest_path | /Users/dubs/Projects/scholia.skill/literature/cs-ai-textbook-canon/ingests/simon_aliferis_healthcare_2024_ch11_ingest.md |
| text_lines_read | 43888–45012 |
| wrong_file_flag | false |

---

## Bibliographic metadata

| Field | Value |
|-------|-------|
| parent_book_title | Artificial Intelligence and Machine Learning in Health Care and Medical Sciences |
| authors | Simon, Gyorgy; Aliferis, Constantin |
| edition | 1st (Springer Health Informatics, 2024) |
| ISBN_print | 978-3-031-39354-9 |
| ISBN_electronic | 978-3-031-39355-6 |
| DOI | https://doi.org/10.1007/978-3-031-39355-6 |
| chapter_number | 11 (selective) / 17 (book) |
| chapter_title | Reporting Standards, Certification/Accreditation, and Reproducibility |
| page_range | [not in text export] |

---

## Scope

Book chapter 17 addresses **documentation and institutional readiness** for health AI/ML: why reporting standards matter for independent appraisal, replication, and liability; the **EQUATOR** ecosystem and **TRIPOD** as the primary prediction-model checklist (22 items); limitations of TRIPOD for ML (ex post forensic, no bias assessment, regression-centric); complementary standards **PROBAST** (bias risk), **CHARMS** (systematic review/appraisal), and **RECORD** (EHR retrospective studies); a **59-item synthesis table** mapping items across T/P/C/R by modeling stage; poor TRIPOD adoption in practice (2022 systematic review: <10% for subject flow and predictive performance); **HIMSS AMAM** eight-stage analytic maturity model with strong caution that conventional analytics ≠ AI/ML competency; gaps in **CAHIIM** accreditation, HIMSS certifications, and health-AI-specific professional certification; and conclusions calling for expanded education, certification, and reporting investment.

Out of scope in this slice: Final Synthesis chapter (split to selective ch.12, lines 45013+); appendices A–C (45491–49703); index (49704–52845)—noted in attestation for w3-closeout.

---

## Key findings

All claims **[verified from text]** from lines 43888–45012 unless tagged `[inferred]`.

1. **Purpose of reporting** (lines 43914–43995). Documented intent, construction method, data, intended population, and expected performance enable third-party evaluation, transfer, and refinement. Standards improve reproducibility—not study design quality. Applicable to internal organizational documentation even without publication. Demographics and practice changes necessitate ongoing re-evaluation; documentation supports reconstruction and liability analysis.

2. **Reproducibility crisis context** (lines 44018–44042). Psychology replication: 97% significant in originals vs 36% in replications [3]; ~50% reproducibility in biomedical fields [4–6]; peer predictions correlate with replication success [7]. Reporting guidelines remind authors and reviewers what to include—they do not prescribe methodology.

3. **TRIPOD adoption gap** (lines 44044–44055). 2022 review of 152 ML papers (2019): near-universal interpretation and data source reporting; <10% included subject flow and predictive performance—items TRIPOD authors deem essential for appraisal.

4. **TRIPOD appraisal** (lines 44057–44136). 22-item checklist organized by manuscript section: clinical context, blind outcome/predictor assessment, missing data, feature selection, calibration/discrimination, limitations, funding. **Pitfall 17.3:** TRIPOD does NOT guarantee correctness, freedom from bias, or clinical safety. Five structural limitations: (a) assumes reader knows best practices; (b) ex post forensic not proactive; (c) misrepresentation possible; (d) elements neither complete nor necessary; (e) no bias-risk assessment. AI-focused TRIPOD/PROBAST revisions announced via Delphi [14]. Pitfall: not all ML methods have intercept/baseline hazard.

5. **PROBAST and CHARMS** (lines 44125–44128). PROBAST focuses bias reduction assessment; CHARMS supports study-design pitfall avoidance for systematic reviews.

6. **Four-standard synthesis (Table 1)** (lines 44138–44457). 59 items across study goals, data source, participants, outcomes, predictors, modeling, evaluation, interpretation, supplements—mapped to TRIPOD [T], PROBAST [P], CHARMS [C], RECORD [R]. Purpose: more complete documentation for bias assessment and cross-institution EHR applicability. Book best practices (causal modeling, overfitting controls, equity, regulatory conformance) must supplement Table 1.

7. **Best Practices 17.1–17.2** (lines 44007–44016). Document development, validation, deployment; use reporting standards plus problem-specific extensions from book BPs.

8. **HIMSS AMAM certification** (lines 44478–44554). Eight stages (0–7): no analytics → data warehouse → governance/competency center → stable quality/reporting → process improvement → point-of-care/population health → predictive/genomic → prescriptive/personalized medicine. **Pitfall 17.4:** vast gap between conventional hospital analytics and AI/ML; immature certification risks false institutional confidence and patient harm.

9. **Academic accreditation gaps** (lines 44556–44612). Few specialized health data science / health AI/ML degree programs; no health-AI-specific accreditation; CAHIIM Master's accreditation based on AMIA informatics competencies—not comprehensive AI/ML specialty. HIMSS offers CAHIMS/CPHIMS/CPDHTS; clinical informatics subspecialty exists but not deep AI/ML. **Pitfalls 17.5–17.7:** no health-AI professional society; no AI/ML-specific accreditation/certification; dearth of specialist education programs.

10. **Chapter conclusions** (lines 44614–44621). Field needs focused educational programs, meaningful individual/institutional certification, and comprehensive reporting standards—initial efforts promising but intensive investment required.

---

## Pedagogy

### Learning objectives

1. Distinguish reporting standards from methodological quality requirements.
2. Apply TRIPOD checklist categories to an ML prognostic model manuscript.
3. Articulate five TRIPOD limitations specific to health AI/ML.
4. Use Table 1 synthesis to plan internal model documentation.
5. Critically evaluate institutional analytic-maturity certification for AI/ML readiness.
6. Identify workforce accreditation gaps relevant to deployment governance.

### worked_examples_present

**Y** — Table 1 four-standard synthesis (59 items); AMAM stage table; TRIPOD adoption statistics; classroom exercises on GRIPS, PROBAST, TRIPOD tailoring (lines 44750–44864).

### exercise_hooks

1. Build TRIPOD+PROBAST+CHARMS checklist for internal 7-year diabetes risk model (exercise 7).
2. Map AMAM stages to AMIA competency areas (exercise 9).
3. Propose TRIPOD items from PROBAST bias domains (exercise 5).

---

## Coverage attestation

| Field | Value |
|-------|-------|
| source_path | `/Users/dubs/Projects/scholia.skill/literature/cs-ai-textbook-canon/text/simon_aliferis_healthcare_2024.txt` |
| lines_read | 43888–45012 (inclusive) |
| section_boundary | Starts `Reporting Standards, Certification/Accreditation, and Reproducibility`; ends before `Synthesis of Recommendations, Open Problems and the Study of BPs` (45013) |
| wrong_file_flag | false |
| deferred | Selective ch.12 synthesis (45013–45490); appendices A–C (45491–49703); index (49704–52845) |
| book_chapter_map | Selective ch.11 = book ch.17 |
| ch12_split_note | Distinct Final Synthesis section exists at line 45013 (≥30 words unique body); split to `simon_aliferis_healthcare_2024_ch12_ingest.md` per worker contract |

---

## Operator hooks

**w3_clinical_docs documentation spine.** TRIPOD+extensions align with model cards and internal runbooks; pair with AIE ch.10 eval documentation. **MDCalc `[relevant]`:** Table 1 synthesis is a portable internal-documentation scaffold for clinical prediction tools—supplement with book BPs for safety/equity; do not treat TRIPOD conformance as clinical validation.

### Redundancy

| Canon | Overlap | Distinction |
|-------|---------|-------------|
| Selective ch.10 | GMLP principle 9 → reporting | ch.11 = full standards landscape |
| NAM sec04 | Readiness cadence | Simon = TRIPOD/PROBAST technical depth |
| kaestner_ml_production_2025 | Model documentation | Simon = clinical publication standards |

---

## TEXTBOOK-Q1 verdict

**PASS** — EQUATOR/TRIPOD/PROBAST/CHARMS/RECORD primary citations; adoption statistics; explicit TRIPOD limitation critique; AMAM pitfall flagged; classroom exercises present.

---

## Cross-references

| Reference | Topic |
|-----------|-------|
| Selective ch.10 | GMLP principle 9, regulatory context |
| Selective ch.12 | Consolidated BP checklist (Appendix 3 preview) |
| Book ch.3–6 | Best practices to extend reporting |
| EQUATOR / TRIPOD / PROBAST | External checklists |

---

## Glossary

| Term | Definition |
|------|------------|
| TRIPOD | Transparent Reporting of multivariable Prediction models (22 items) |
| PROBAST | Prediction model Risk Of Bias ASsessment Tool |
| CHARMS | Checklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies |
| RECORD | REporting of studies Conducted using Observational Routinely-collected Data |
| EQUATOR | Network umbrella for 250+ reporting guidelines |
| AMAM | HIMSS Adoption Model of Analytic Maturity (stages 0–7) |

---

*Ingest agent: simon-ingest-ch10-12 · selective ch11 · lines 43888–45012 · word cap ≤4500*
